Clinical Utility of Oxford Cognitive Screen Test to Screen Cognitive Impairment in Post Stroke Patients
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this type of study: clinical trial is to assess K-OCS clinical utility in participant population. The main aims: validate the reliability and validity of the Korean version of the Oxford Cognitive Screen (K-OCS) analyze its sensitivity, specificity, and diagnostic accuracy, and compare its examination participation rates with existing assessment tools to determine the effectiveness of K-OCS in detecting post-stroke cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedApril 5, 2024
March 1, 2024
3.5 years
March 31, 2024
March 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of K-OCS
Measurement of k-ocs is a process of validating K-OCS and assess its clinical utility
Between November 2020 and April 2022
Secondary Outcomes (4)
Measurement of Korean version of mini-mental state examination (K-MMSE)
Between November 2020 and April 2022
Measurement Korean Version of the Oxford cognitive screen (K-OCS)
Between November 2020 and April 2022
Measurement of national institute of health care stroke scale (NIHSS)
Between November 2020 and April 2022
Measurement of fuctional independence meausure (FIM)
Between November 2020 and April 2022
Study Arms (1)
Healthy subjects and Stroke patients
Healthy subjects and Stroke patients
Eligibility Criteria
Stroke patients and healthy voluteers
You may qualify if:
- Adults over 20 years of age
- More than 72 hours elapsed since the onset of stroke symptoms.
- After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- Involved individuals diagnosed with stroke by neurology and rehabilitation medicine specialists based on data acquired from 3T GE Signa System (General Electric, Milwaukee, WI), brain magnetic resonance imaging (MRI), and computed tomography (CT).
You may not qualify if:
- For healthy voluteers
- Over 20 years of age
- A person who is performing an independent daily life
- A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Rehabilitation Medicine, CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, 13496, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
March 31, 2024
First Posted
April 5, 2024
Study Start
September 1, 2021
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
April 5, 2024
Record last verified: 2024-03